Rehovot, Israel

Rina Arad-Yellin

This inventor holds 5 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Yeda Research and Develpment & Co. Ltd, Semorex Inc.. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rina Arad-Yellin. Retrieved from https://idiyas.com/inventor/rina-arad-yellin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Rehovot, IL (2013 - 2016)
  • Rechovot, IL (2012 - 2018)

Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Rina Arad-Yellin: Innovator in Antibody Research

Introduction

Rina Arad-Yellin is a prominent inventor based in Rechovot, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and pharmaceutical compositions. With a total of 5 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins." This patent describes an antibody that comprises an antigen recognition region featuring CDR amino acid sequences set forth in SEQ ID NO: 7, 8, 9, 10, 11, and 12. This innovative approach aims to provide new therapeutic options for conditions related to metalloprotein activity.

Career Highlights

Rina has worked with notable organizations such as Yeda Research and Development Company and Semorex Inc. Her experience in these companies has allowed her to refine her expertise in antibody research and development.

Collaborations

Rina has collaborated with esteemed colleagues, including Irit Sagi and Tamar Danon. These partnerships have further enhanced her research and contributed to her success in the field.

Conclusion

Rina Arad-Yellin's contributions to antibody research exemplify her dedication to innovation in biotechnology. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…